The results of three randomised trials showed no long term clinical benefit with atherectomy.'-3 The higher incidence of composite end points including myocardial infarction and acute abrupt closure has made DCA an unfavourable tool. It is of limited value for calcified lesions. The large, rigid guide catheter and the cutting device carry a substantial risk in an inexperienced hand. Inappropriate placement of the guiding catheter may result in ostial dissection. Serious femoral vascular complications may occur because of the larger groin puncture. DCA is a difficult, time consuming, and demanding procedure; it requires a long learning curve and regular use is necessary to maintain skill. DCA has become less attractive with the increasing availability of stents, the majority of which can be deployed using 6F catheters. Ticlopidine instead of warfarin has allowed stenting to be carried out with fewer complications thus reducing length of hospital stay and overall costs. Stenting has thus largely replaced DCA for many complex lesions. DCA should be reserved for the treatment of lesions such as proximal bulky, eccentric, ostial, and bifurcation lesions. It will continue to remain a unique research tool for obtaining specimens of human coronary atheroma.
then why is it not used more often? 
If directional coronary atherectomy is useful

